UNI MEDICAL (02666) completed the domestic public issuance of the second phase corporate bonds in China in 2025.

UNI MEDICAL (02666) announced that its wholly-owned subsidiary, China Global Leasing Co., Ltd. (Issuer), has publicly issued the 2025 second series corporate bonds (this series of corporate bonds) within the People's Republic of China (China). The company is pleased to announce that this series of corporate bonds was successfully issued in China on January 21, 2025. The total principal amount of this series of corporate bonds is RMB 600 million, with a base term of five years starting from January 21, 2025, and a fixed interest rate of 2.10%. At the end of the first year, second year, third year, and fourth year, the Issuer will have the redemption option and the option to adjust the face interest rate, while investors will have the put option. The issue price is RMB 100 per share, which is equivalent to 100% of the face value of this series of corporate bonds.